IRIDEX Corporation IRIX
0.73 USD +0.08 (+11.67%)
Nov 12, 2026, 2:01 PM EST
0.7147 Day range 0.7294
0.61 52-week range 1.65
- YTD
- -36.03%
- 1 year
- -23.23%
News
benzinga.com 12 Health Care Stocks Moving In Monday's Pre-Market Session Gainers SciSparc (NASDAQ:SPRC) shares moved upwards by 39.4% to $1.52 during Monday's pre-market session. Xencor (NASDAQ:XNCR) stock moved upwards by 29.46% to $32.6. The company's market cap stands…
benzinga.com Iridex Announces Publication Of 2-Yr Clinical Study Demonstrating Favorable Outcomes With TLT Using MicroPulse Technology In Patients With Primary Glaucoma Iridex Corporation (NASDAQ:IRIX), a worldwide leader in innovative laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal diseases, today announced…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session Gainers ZeroStack (NASDAQ:ZSTK) stock increased by 440.2% to $9.94 during Wednesday's regular session. The company's market cap stands at $4.4 million. Tenon Medical (NASDAQ:TNON) shares moved…
benzinga.com Full Transcript: Iridex Q2 2026 Earnings Call Iridex (NASDAQ:IRIX) held its second-quarter earnings conference call on Tuesday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call transcripts…
benzinga.com Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.
benzinga.com Iridex Q2 EPS $(0.07) Misses $(0.01) Estimate, Sales $12.566M Miss $13.587M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.01) by 600 percent. This is a 16.67 percent decrease over losses of $(0.06) per…- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session Gainers P3 Health Partners (NASDAQ:PIII) shares increased by 24.1% to $15.92 during Monday's after-market session. The market value of their outstanding shares is at $38.5 million. As per the press…
- benzinga.com Iridex Expands Its EyeProGPO Product Offering To Include The Company’s Line Of EndoProbe Handpieces Through the agreement, more than 4,300 EyeProGPO members will have access to preferred pricing on Iridex EndoProbe Handpieces, expanding the value Iridex provides to ophthalmology practices,…
- benzinga.com Iridex Q1 2026 Earnings Call: Complete Transcript
benzinga.com Iridex Affirms FY2026 Sales Guidance of $51.000M-$53.000M vs $53.227M Est Iridex (NASDAQ:IRIX) affirms FY2026 sales outlook from $51.000 million-$53.000 million to $51.000 million-$53.000 million vs $53.227 million estimate.- benzinga.com Iridex Q1 EPS $(0.03) Beats $(0.07) Estimate, Sales $11.799M Miss $11.910M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.07) by 57.14 percent. This is a 70 percent increase over losses of $(0.10) per…
benzinga.com Earnings Scheduled For May 19, 2026 - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session
benzinga.com Iridex Q4 EPS $(0.01) Beats $(0.02) Estimate, Sales $14.724M Miss $14.740M Estimate. Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.02) by 50 percent. This is a 80 percent increase over losses of $(0.05) per share…- benzinga.com Earnings Scheduled For March 26, 2026
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session
benzinga.com Iridex Reports Preliminary Q4 2025 Revenue Of $14.6M–$14.8M, Up 15%–17% YoY, And Full-Year Revenue Of $52.5M–$52.7M, Up 8% YoY, While Achieving Positive Cash Flow And Adjusted EBITDA Fourth Quarter 2025 ResultsTotal revenue is expected to be between $14.6 million and $14.8 million compared to $12.7 million in the prior year quarter, representing year-over-year growth between 15%…- benzinga.com New Study Shows Iridex Laser Treatment Safely Lowers Eye Pressure for Glaucoma Patients Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems, delivery devices, and accessories for the treatment of glaucoma and retinal…
benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session - benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why LightPath Technologies Shares Are Trading Higher By 7%; Here Are 20 Stocks Moving Premarket 
benzinga.com Iridex Q3 EPS $(0.09) Up From $(0.12) YoY, Sales $12.484M Up From $11.581M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.09) per share. This is a 25 percent increase over losses of $(0.12) per share from the same period last year. The company reported $12.484…
benzinga.com Earnings Scheduled For November 11, 2025 - benzinga.com CORRECTION: Iridex Q2 EPS $(0.06) Misses $0.06 Estimate, Sales $13.57M Up From $12.63M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.06) per share which missed the analyst consensus estimate of $0.06 by 200 percent. This is a 62.5 percent increase over losses of $(0.16) per…
benzinga.com Earnings Scheduled For August 12, 2025 - benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session - benzinga.com Iridex Q1 GAAP EPS $(0.10) Up From $(0.21) YoY, Sales $11.90M Up From $11.76M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.10) per share. This is a 52.38 percent increase over losses of $(0.21) per share from the same period last year. The company reported $11.90…
- benzinga.com Earnings Scheduled For May 13, 2025
benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Iridex Q4 EPS $(0.05) Up From $(0.18) YoY, Sales $12.70M Up From $12.46M YoY Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.05) per share. This is a 72.22 percent increase over losses of $(0.18) per share from the same period last year. The company reported $12.70…
- benzinga.com Earnings Scheduled For March 27, 2025
- benzinga.com Earnings Preview For Iridex
- benzinga.com Iridex Announces $10M Investment From Novel Inspiration; $6M Series B Preferred Stock Sale & $4M Convertible Notes, With Option For Additional $10M Growth Notes Iridex Corporation (NASDAQ:IRIX), a worldwide leader providing innovative and versatile laser-based medical systems and delivery devices for the treatment of glaucoma and retinal diseases, today…
- benzinga.com 12 Health Care Stocks Moving In Friday's Pre-Market Session
- benzinga.com Iridex Q3 EPS $(0.12) Misses $(0.09) Estimate, Sales $11.58M Miss $12.50M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.12) per share which missed the analyst consensus estimate of $(0.09) by 33.33 percent. This is a 9.09 percent decrease over losses of $(0.11) per…
- benzinga.com Earnings Scheduled For November 12, 2024
- benzinga.com Insights into Iridex's Upcoming Earnings
- benzinga.com Iridex Q2 2024 GAAP EPS $(0.16) Misses $(0.11) Estimate, Sales $12.631M Miss $12.800M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.11) by 45.45 percent. This is a 5.88 percent increase over losses of $(0.17) per…
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Iridex Q1 2024 GAAP EPS $(0.21) Misses $(0.12) Estimate, Sales $11.76M Miss $12.00M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.12) by 75 percent. This is a 61.54 percent decrease over losses of $(0.13) per…
benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com Iridex: Q4 Earnings Insights
- benzinga.com Iridex Q4 2023 GAAP EPS $(0.18) Misses $(0.05) Estimate, Sales $12.458M Miss $14.900M Estimate Iridex (NASDAQ:IRIX) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.05) by 260 percent. The company reported quarterly sales of $12.458 million…
- benzinga.com Earnings Scheduled For March 26, 2024 Companies Reporting Before The Bell • bluebird bio (NASDAQ:BLUE) is likely to report quarterly loss at $0.66 per share on revenue of $16.68 million.